TP53 and hepatocellular carcinoma: Furthermore, TP53 mutations are associated with lower survival among patients with HBV-related HCC but not among those with HCC related to another etiology, suggesting a prognostic value of these mutations only in this specific group of particularly aggressive HCC [27].